PLoS ONE · 2013 · 38 citations · 47 references
Life SciencesCell BiologyImmunologyCell SignalingInflammationSignal TransductionEndothelial DysfunctionInflammatory MediatorsInflammatory SignalingLeukocyte RecruitmentLeukocyte TraffickingVascular PermeabilityCellular Adhesion MoleculesCytokine-mediated Leukocyte RecruitmentEndothelial Adhesion MoleculesEndothelial Cell AdhesionEndothelial Inflammatory SignalingInflammatory Cytokine EffectsOxidative Stress InjuryVascular Endothelial Dysfunction
Endothelial cells participate in inflammatory events leading to atherogenesis by regulating endothelial cell permeability via the expression of VE-Cadherin and β-catenin and leukocyte recruitment via the expression of E-Selectins and other adhesion molecules. The protein p66(Shc) acts as a sensor/inducer of oxidative stress and may promote vascular dysfunction. The objective of this study was to investigate the role of p66(Shc) in tumor necrosis factor TNFα-induced E-Selectin expression and function in human umbilical vein endothelial cells (HUVEC). Exposure of HUVEC to 50 ng/ml TNFα resulted in increased leukocyte transmigration through the endothelial monolayer and E-Selectin expression, in association with augmented phosphorylation of both p66(Shc) on Ser(36) and the stress kinase c-Jun NH2-terminal protein kinase (JNK)-1/2, and higher intracellular reactive oxygen species (ROS) levels. Overexpression of p66(Shc) in HUVEC resulted in enhanced p66(Shc) phosphorylation on Ser(36), increased ROS and E-Selectin levels, and amplified endothelial cell permeability and leukocyte transmigration through the HUVEC monolayer. Conversely, overexpression of a phosphorylation-defective p66(Shc) protein, in which Ser(36) was replaced by Ala, did not augment ROS and E-Selectin levels, nor modify cell permeability or leukocyte transmigration beyond those found in wild-type cells. Moreover, siRNA-mediated silencing of p66(Shc) resulted in marked reduction of E-Selectin expression and leukocyte transmigration. In conclusion, p66(Shc) acts as a novel intermediate in the TNFα pathway mediating endothelial dysfunction, and its action requires JNK-dependent phosphorylation of p66(Shc) on Ser(36).
47
The p66shc adaptor protein controls oxidative stress response and life span in mammals
Enrica Migliaccio, Marco Giorgio, Simonetta Mele et al. · Nature · 1999 · 1.7K citations
Cell-Permeable Peptide Inhibitors of JNK
Christophe Bonny, Anne Oberson, Stéphanie Negri et al. · Diabetes · 2001 · 570 citations · Full text
Robert Rothlein, Michele Czajkowski, Maeve O'Neill et al. · The Journal of Immunology · 1988 · 569 citations · Full text